MoonLake Immunotherapeutics (MLTX) Earnings Date
The next earnings date for MoonLake Immunotherapeutics (MLTX) is around Feb 22, 2027, estimated from its own calendar.
- Next earnings date
- Around Feb 22, 2027
- estimated from its own calendar · quarter ending Dec '26
- Latest stored quarter
- EPS −0.93
- revenue $0.00 · reported Nov 4, 2026
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
Estimate-vs-actual scoring began Jul 2026. Earlier quarters predate our snapshots, so their surprise stays "—". We never backfill an estimate we didn't observe.
| Report | Est EPS | Act EPS | Est rev | Act rev | Reaction |
|---|---|---|---|---|---|
| Nov 4, 20268-K, before open · 7:00 am ET | −0.78 | −0.93 | $0.00 | $0.00 | −1.2%release day |
| Aug 10, 20268-K, before open · 7:15 am ET | −0.92 | −1.68 | $0.00 | $0.00 | −5.1%release day |
| May 11, 20268-K, before open · 7:09 am ET | — | −0.98 | — | $0.00 | +10.4%release day |
| Feb 23, 20268-K, before open · 6:04 am ET | — | −0.93 | — | — | −0.5%release day |
| Nov 5, 20258-K, before open · 7:00 am ET | — | −1.10 | — | $0.00 | +4.5%release day |
| Aug 5, 20258-K, before open · 7:01 am ET | — | −1.74 | — | $0.00 | +0.2%release day |
| May 12, 20258-K, after close · 4:01 pm ET | — | −0.63 | — | $0.00 | −4.1%next session |
| Feb 26, 20258-K, before open · 7:09 am ET | — | −0.72 | — | — | +4.0%release day |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 6 | 2 | 7 | 8 |
| Avg estimate | −0.86 | −0.89 | −3.57 | −3.55 |
| Low estimate | −1.00 | −0.90 | −3.68 | −4.07 |
| High estimate | −0.75 | −0.87 | −3.41 | −3.03 |
| Year-ago EPS | −0.93 | −0.98 | −3.53 | −3.57E |
| Implied growth | — | — | — | — |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 0 | 8 | 0 | 9 |
| Avg estimate | $0.00 | $119,600.00 | $0.00 | $18.2M |
| Low estimate | $0.00 | $119,600.00 | $0.00 | $11.1M |
| High estimate | $0.00 | $119,600.00 | $0.00 | $24.2M |
| Year-ago revenue | — | $0.00 | $0.00 | $0.00E |
| Implied growth | — | — | — | — |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 | FY26, period ending Dec 31, 2026 | FY27, period ending Dec 31, 2027 |
|---|---|---|---|---|
| Current estimate | −0.86 | −0.89 | −3.57 | −3.55 |
| 7 days ago | −0.83 | — | −3.51 | −3.53 |
| 30 days ago | −0.81 | — | −3.37 | −3.41 |
| 60 days ago | −0.82 | — | −3.37 | −3.41 |
| 90 days ago | −0.91 | — | −3.80 | −3.60 |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $−0.91 → $−0.86 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
When does MoonLake Immunotherapeutics report earnings next?
MoonLake Immunotherapeutics' next earnings date is around Feb 22, 2027, estimated from its own calendar.
What were MoonLake Immunotherapeutics' latest quarterly earnings?
MoonLake Immunotherapeutics reported diluted EPS of −0.93 and revenue of $0.00 on Nov 4, 2026.
How did MoonLake Immunotherapeutics' stock move after its last earnings report?
MoonLake Immunotherapeutics moved −1.2% in the session after its Nov 4, 2026 report.

